DNLI Financing Cash Flow

Denali Therapeutics Inc · Financing Cash Flow

DNLI logo

DNLI Financing Cash Flow

Latest reported$425.38M
DNLI TTM Cash from Financing ($300.48M → $425.38M)
High-resolution chart · PNG

DNLI financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Denali Therapeutics Inc Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
425,383,000
412,022,000
189,216,000
-7,085,000
-24,866,000
-19,733,000
484,304,000
493,177,000
514,228,000
516,491,000
17,820,000
312,766,000
315,428,000
310,811,000
310,670,000
16,187,000
14,348,000
16,989,000
19,348,000
23,702,000
446,286,000
442,658,000
634,749,000
627,260,999
202,040,999
201,194,999
6,189,999
5,846,000
5,825,000
4,688,000
97,019,000
390,920,000
390,619,000
389,238,000
296,323,000
728,000
8,065,000
154,407,000
300,476,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.